syngo Neuro PBV IR Displays Cerebral Blood Flow During Interventional Procedures

Siemens HealthcareWith syngo Neuro PBV IR (Parenchymal Blood Volume, Interventional Suite), Siemens Healthcare has developed a new application for interventional radiology that allows you to review parenchymal blood flow during minimally invasive interventions in the brain for the first time. This feature assists the neuroradiologist in the treatment of stroke patients by displaying the condition of the cerebral tissue directly in the angio suite. syngo Neuro PBV IR further expands the Siemens imaging application portfolio for Artis zee, the Siemens systems for interventional radiology and cardiology.

According to the World Health Organization (WHO), approximately 15 million people suffer from stroke every year. A stroke results from decreased blood flow in the brain, which frequently causes irreparable damage of the cerebral tissue. The earlier a stroke is treated, the larger the chance that as little brain tissue as possible is destroyed. To further shorten the time from diagnosis to treatment, Siemens Healthcare has developed the software syngo Neuro PBV IR, which directly displays the status of the cerebral tissue during minimally invasive procedures. Minimally invasive techniques for stroke treatment involve the use of a thin catheter within the arteries of the brain to either deliver a drug to dissolve the blood clot or a special catheter to mechanically remove it.

Syngo Neuro PBV IR for the first time provides neuroradiologists with current information about the status of the brain tissue during minimally invasive procedures. This not only results in clinical advantages for stroke treatment, but is equally helpful for tumor biopsy and treatment, tissue embolization, and vasospasm therapy (spasms of blood vessels).

Another benefit of the new Siemens software is that it is capable of providing blood volume data for the whole brain, unlike traditional CT acquisition, and allows the clinician to review the information from any orientation, axial, coronal, sagittal etc. Syngo Neuro PBV IR uses cone-beam CT technology (syngo DynaCT) to acquire the information required for such advanced tissue visualization. This proprietary Siemens development from 2004 led to a paradigm shift in angiographic imaging, introducing the ability to view cross sectional soft tissue information with an angiographic C-arm system for the first time.

All that is required to generate the PBV information is two C-arm rotations around the patient and a steady state contrast injection. The sophisticated processing algorithms of the system use the resulting data to generate a neurological PBV map. The information is available at tableside, in less than 40 seconds, without the need for any further user interaction.

Syngo Neuro PBV IR further expands the Siemens imaging application portfolio for Artis zee. Artis zee is the product family name of Siemens systems used for interventional radiology and cardiology. These systems are available in biplane, multi-axial, ceiling-mounted, floor-mounted, and multi-functional configurations.

Syngo Neuro PBV IR is the second functional imaging application for the Artis zee portfolio after the successful launch of syngo iFlow. The application syngo iFlow allows for the display of the functional information inherent in a digital subtraction angiography (DSA) series in a single color image. Syngo Neuro PBV IR was first introduced to the public at the 2009 Annual Meeting of the Radiological Society of North America (RSNA).

Related news articles:

About Siemens Healthcare
The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens offers its customers products and solutions for the entire range of patient care from a single source - from prevention and early detection to diagnosis, and on to treatment and aftercare. By optimizing clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 48,000 employees worldwide and operates around the world. In fiscal year 2009 (to September 30), the Sector posted revenue of 11.9 billion euros and profit of around 1.5 billion euros. For further information please visit: www.siemens.com/healthcare.

Most Popular Now

Almost All Leading AI Chatbots Show Sign…

Almost all leading large language models or "chatbots" show signs of mild cognitive impairment in tests widely used to spot early signs of dementia, finds a study in the Christmas...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Emotional Cognition Analysis Enables Nea…

A joint research team from the University of Canberra and Kuwait College of Science and Technology has achieved groundbreaking detection of Parkinson's disease with near-perfect accuracy, simply by analyzing brain...

New Recommendations to Increase Transpar…

Patients will be better able to benefit from innovations in medical artificial intelligence (AI) if a new set of internationally-agreed recommendations are followed. A new set of recommendations published in The...

Digital Health Unveils Draft Programme f…

18 - 19 March 2025, Birmingham, UK. Digital Health has unveiled the draft programme for its Rewired 2025 event which will take place at the NEC in Birmingham in March next...

AI System Helps Doctors Identify Patient…

A new study from Vanderbilt University Medical Center shows that clinical alerts driven by artificial intelligence (AI) can help doctors identify patients at risk for suicide, potentially improving prevention efforts...

Smartphone App can Help Reduce Opioid Us…

Patients with opioid use disorder can reduce their days of opioid use and stay in treatment longer when using a smartphone app as supportive therapy in combination with medication, a...

AI's New Move: Transforming Skin Ca…

Pioneering research has unveiled a powerful new tool in the fight against skin cancer, combining cutting-edge artificial intelligence (AI) with deep learning to enhance the precision of skin lesion classification...

Leveraging AI to Assist Clinicians with …

Physical examinations are important diagnostic tools that can reveal critical insights into a patient's health, but complex conditions may be overlooked if a clinician lacks specialized training in that area...

AI can Improve Ovarian Cancer Diagnoses

A new international study led by researchers at Karolinska Institutet in Sweden shows that AI-based models can outperform human experts at identifying ovarian cancer in ultrasound images. The study is...

Major EU Project to Investigate Societal…

A new €3 million EU research project led by University College Dublin (UCD) Centre for Digital Policy will explore the benefits and risks of Artificial Intelligence (AI) from a societal...

Predicting the Progression of Autoimmune…

Autoimmune diseases, where the immune system mistakenly attacks the body's own healthy cells and tissues, often have a preclinical stage before diagnosis that’s characterized by mild symptoms or certain antibodies...